Mashhad University of Medical Sciences
Also known as: Department of Heart failure , Imam reza hospital, Mashhad, Iran | Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ENT department of Mashhad azad university of mashhad | Eye Research Center, Cornea Research Center, Mashhad University of Medical Sciences | Imam reza hospital, Mashhad, Iran | Mashhad Razavi Hospital | mashhad UMS | Mashhad University of Medical Science | Mashhad University of Medical Sciences | Mashhad University of Medical Sciences, Mashhad, Iran | Medical Surgical Nursing Department, Mashhad University of Medical Sciences | Midwifery department, Islamic Azad Medical University, Mashhad branc, Mashhad, Iran | Omid Hospital, Mashhad University of Medical Sciences, Mashhad, Iran | oral medicine dep, dental school, mashhad university of medical science | Postgraduate Department, Mashhad University of Medical Sciences | Retina Research Center, Mashhad University of Medical Sciences, Mashhad, Iran | Rheumatic Diseases Research Center, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | Sara Saeidi Shahri | School of Persian and Complementary medicine, Mashhad University of Medical Sciences, Mashhad, Iran | Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. | University of Mashhad
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2005Last known activity
Oct 21, 2025
Timeline
1940s
- Jan 1, 1949
Mashhad University of Medical Sciences— Founded
Drugs by trial phase (75 distinct, 59 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (17 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alzheimer Disease
- Angina Pectoris
- Angina, Stable
- Anxiety Disorders
- Arthritis
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Astrocytoma
- Atrophy
- Bacteriuria
- Brain Injuries
- Brain Injuries, Traumatic
- Communicable Diseases
- Cross Infection
- Dental Pulp Diseases
- Diabetic Foot
- Esophageal Neoplasms
- Foot Ulcer
- Gangliosidoses
- Gangliosidoses, GM2
- Glaucoma
- Glaucoma, Open-Angle
- Glioblastoma
- Head and Neck Neoplasms
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Infections
- Inflammation
- Labor Pain
- Leishmaniasis
- Leishmaniasis, Cutaneous
- Lichen Planus
- Lichen Planus, Oral
- Mucositis
- Nausea
- Optic Nerve Diseases
- Optic Nerve Injuries
- Orbital Pseudotumor
- Osteoarthritis
- Osteoarthritis, Knee
- Peripheral Nervous System Diseases
- Pulpitis
- Stomatitis
- Stomatitis, Aphthous
- Syndrome
- Tay-Sachs Disease
- Thyroid Diseases
- Thyroid Neoplasms
- Tinnitus
- Tooth Diseases
- Ulcer
- Urinary Tract Infections
- Vomiting
- Wounds and Injuries
Recent trials (50)
- NCT07311070Lead sponsorPhase 3Oct 21, 2025
- NCT07311057Lead sponsorPhase 3Oct 21, 2025
- NCT07311070Sponsor investigatorPhase 3Oct 21, 2025
- NCT07311057Sponsor investigatorPhase 3Oct 21, 2025
- NCT05983302Sponsor investigatorPhase 2/Phase 3Aug 20, 2023
- NCT05983302Lead sponsorPhase 2/Phase 3Aug 20, 2023
- NCT05983302Reponsible party - principal investigatorPhase 2/Phase 3Aug 20, 2023
- NCT05983302OfficialPhase 2/Phase 3Aug 20, 2023
- NCT05850611Lead sponsorEarly Phase 1Apr 30, 2023
- NCT05850611Reponsible party - principal investigatorEarly Phase 1Apr 30, 2023
- NCT05850611Overall official - principal investigatorEarly Phase 1Apr 30, 2023
- NCT04663854Reponsible party - principal investigatorPhase 1Aug 20, 2020
- NCT04663854Lead sponsorPhase 1Aug 20, 2020
- NCT04370288Lead sponsorPhase 1Apr 19, 2020
- NCT04370288Overall official - principal investigatorPhase 1Apr 19, 2020
Details
- Founded
- Mashhad, IR Jan 1, 1949
- Last known activity
- Oct 21, 2025